<scp>GLP</scp> ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations
Abstract Aim To pool the incremental net benefits (INBs) of using glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) for treating obesity without diabetes. Materials and Metho...